Steigerwald, Gordon & Koch Inc. Cellebrite Di Ltd. Transaction History
Steigerwald, Gordon & Koch Inc.
- $977 Million
- Q3 2025
A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 95 shares of CLBT stock, worth $1,714. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95Holding current value
$1,714% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLBT
# of Institutions
216Shares Held
98.9MCall Options Held
122KPut Options Held
80.8K-
True Wind Capital Management, L.P.13.9MShares$250 Million94.16% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.52MShares$118 Million0.07% of portfolio
-
Voss Capital, LLC Houston, TX5.15MShares$93 Million6.92% of portfolio
-
Morgan Stanley New York, NY4.65MShares$84 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA3.51MShares$63.3 Million0.01% of portfolio
About Cellebrite DI Ltd.
- Ticker CLBT
- Exchange NASDAQ
- Sector Technology
- Industry Software—Infrastructure
- Shares Outstandng 189,648,992
- Market Cap $3.42B
- Description
- Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...